Aldeyra Therapeutics, Inc. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aldeyra Therapeutics, Inc. annual/quarterly Return On Equity history and growth rate from 2014 to 2023.
  • Aldeyra Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2023 was -33.8 %.
  • Aldeyra Therapeutics, Inc. annual Return On Equity for 2023 was -29.5 %, a 19.5% increase from 2022.
  • Aldeyra Therapeutics, Inc. annual Return On Equity for 2022 was -36.6 %, a 24.3% decline from 2021.
  • Aldeyra Therapeutics, Inc. annual Return On Equity for 2021 was -29.4 %, a 55.9% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -29.5 +7.15 +19.5% Jan 1, 2023 Dec 31, 2023
2022 -36.6 -7.16 -24.3% Jan 1, 2022 Dec 31, 2022
2021 -29.4 +37.4 +55.9% Jan 1, 2021 Dec 31, 2021
2020 -66.8 +32.6 +32.8% Jan 1, 2020 Dec 31, 2020
2019 -99.4 -16.7 -20.2% Jan 1, 2019 Dec 31, 2019
2018 -82.7 -17.4 -26.6% Jan 1, 2018 Dec 31, 2018
2017 -65.3 +11.5 +15% Jan 1, 2017 Dec 31, 2017
2016 -76.8 -27.9 -57.1% Jan 1, 2016 Dec 31, 2016
2015 -48.9 -185 -136% Jan 1, 2015 Dec 31, 2015
2014 136 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.